Glp-1

Understanding the timeline for weight loss with Mounjaro, factors influencing results, and what to expect on your journey.

Zepbound (tirzepatide) is one of the most effective pharmaceutical weight loss treatments available. This article covers its dual GLP-1/GIP mechanism, the SURMOUNT trial evidence, side effects, who qualifies, and how it compares to other GLP-1 medications.

Oprah Winfrey's public disclosure of using weight loss medication brought GLP-1 receptor agonists into mainstream conversation. This article examines what the clinical evidence shows about these medications, who qualifies for them, and what realistic expectations look like.

Approximately 14% of participants in the STEP 1 trial lost less than 5% body weight on semaglutide. Non-response and plateaus have specific causes: inadequate dose escalation, calorie intake above deficit despite reduced appetite, and metabolic adaptation. This article reviews what the evidence shows and what to do.

Kelly Clarkson publicly confirmed in 2024 that she used a weight loss drug (consistent with GLP-1 receptor agonists) alongside dietary changes and walking. This article covers what GLP-1 medications actually do, the evidence behind them, and what realistic outcomes look like for people considering similar approaches.